Related Experiment Video
Updated: Nov 29, 2025

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
Tuberculosis-Related Uveitis in Patients under Anti-TNF-alpha Therapy: A Case Series
I Hernanz1, L Miguel Escuder1, L Chamorro1
1Hospital Clinic of Barcelona, Clínic Institute of Ophthalmology, University of Barcelona, Barcelona, Spain.
Tumor necrosis factor inhibitors treat noninfectious uveitis but can reactivate tuberculosis (TB). Even with negative screening, TB reactivation is a risk in patients on anti-TNF therapy experiencing atypical uveitis.
Area of Science:
- Ophthalmology
- Immunology
- Infectious Diseases
Background:
- Noninfectious uveitis (NIU) is effectively treated with tumor necrosis factor inhibitors (anti-TNF).
- Anti-TNF therapy can increase susceptibility to infections, notably tuberculosis (TB).
- Diagnosing TB-related uveitis in patients with concurrent immune-mediated diseases on anti-TNF poses a significant challenge.
Purpose of the Study:
- To highlight the diagnostic challenges and clinical presentation of TB reactivation in patients with noninfectious uveitis treated with anti-TNF therapy.
Main Methods:
- Retrospective chart review of patients treated with anti-TNF for systemic immune-mediated diseases.
- Analysis of cases with microbiologically confirmed active TB and concurrent intraocular involvement.
Main Results:
- Three patients with microbiologically confirmed extraocular TB and intraocular involvement were identified.
- Two patients had negative TB screening before anti-TNF initiation; one had prior TB treatment.
- All patients experienced atypical uveitis reactivation with a shift to a chronic granulomatous pattern.
Conclusions:
- Ophthalmologists and specialists must consider TB reactivation in patients on anti-TNF therapy presenting with atypical uveitis, even if initial TB screening was negative.
- Awareness of TB reactivation is crucial when uveitis signs and activity deviate from expected patterns in patients receiving anti-TNF treatment.
- This rare context of TB-related uveitis requires heightened clinical suspicion and diagnostic vigilance.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

